158 related articles for article (PubMed ID: 14735295)
1. Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.
Cohrs S; Pohlmann K; Guan Z; Jordan W; Meier A; Huether G; Rüther E; Rodenbeck A
Psychopharmacology (Berl); 2004 Jul; 174(3):414-20. PubMed ID: 14735295
[TBL] [Abstract][Full Text] [Related]
2. Ziprasidone decreases cortisol excretion in healthy subjects.
Meier A; Neumann AC; Jordan W; Huether G; Rodenbeck A; Rüther E; Cohrs S
Br J Clin Pharmacol; 2005 Sep; 60(3):330-6. PubMed ID: 16120074
[TBL] [Abstract][Full Text] [Related]
3. Sleep-promoting properties of quetiapine in healthy subjects.
Cohrs S; Rodenbeck A; Guan Z; Pohlmann K; Jordan W; Meier A; Rüther E
Psychopharmacology (Berl); 2004 Jul; 174(3):421-9. PubMed ID: 15029469
[TBL] [Abstract][Full Text] [Related]
4. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
Cohrs S; Röher C; Jordan W; Meier A; Huether G; Wuttke W; Rüther E; Rodenbeck A
Psychopharmacology (Berl); 2006 Mar; 185(1):11-8. PubMed ID: 16432682
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine effects of quetiapine in healthy volunteers.
de Borja Gonçalves Guerra A; Castel S; Benedito-Silva AA; Calil HM
Int J Neuropsychopharmacol; 2005 Mar; 8(1):49-57. PubMed ID: 15469666
[TBL] [Abstract][Full Text] [Related]
6. Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion.
Derenzo J; Macknight B; DiVittore NA; Bonafide CP; Cronin AJ
Acta Anaesthesiol Scand; 2005 Jan; 49(1):52-7. PubMed ID: 15675982
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human motor cortex excitability by quetiapine.
Langguth B; Eichhammer P; Spranz C; Landgrebe M; Frick U; Sand P; Hajak G
Psychopharmacology (Berl); 2008 Mar; 196(4):623-9. PubMed ID: 18038224
[TBL] [Abstract][Full Text] [Related]
8. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects.
Hack LM; Lockley SW; Arendt J; Skene DJ
J Biol Rhythms; 2003 Oct; 18(5):420-9. PubMed ID: 14582858
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms.
Rock PL; Goodwin GM; Wulff K; McTavish SF; Harmer CJ
J Psychopharmacol; 2016 Mar; 30(3):273-82. PubMed ID: 26869012
[TBL] [Abstract][Full Text] [Related]
11. Effects of temazepam on sleep, performance, and rhythmic 6-sulphatoxymelatonin and cortisol excretion after transmeridian travel.
Donaldson E; Kennaway DJ
Aviat Space Environ Med; 1991 Jul; 62(7):654-60. PubMed ID: 1898301
[TBL] [Abstract][Full Text] [Related]
12. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
13. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
14. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
Buckley TM; Mullen BC; Schatzberg AF
Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
[TBL] [Abstract][Full Text] [Related]
16. Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans.
McIntyre IM; Norman TR; Burrows GD; Armstrong SM
Chronobiol Int; 1993 Jun; 10(3):205-13. PubMed ID: 8319319
[TBL] [Abstract][Full Text] [Related]
17. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus.
Xu H; Qing H; Lu W; Keegan D; Richardson JS; Chlan-Fourney J; Li XM
Neurosci Lett; 2002 Mar; 321(1-2):65-8. PubMed ID: 11872258
[TBL] [Abstract][Full Text] [Related]
19. Melatonin enhances cortisol levels in aged but not young women.
Cagnacci A; Soldani R; Yen SS
Eur J Endocrinol; 1995 Dec; 133(6):691-5. PubMed ID: 8548054
[TBL] [Abstract][Full Text] [Related]
20. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial.
Katzman MA; Brawman-Mintzer O; Reyes EB; Olausson B; Liu S; Eriksson H
Int Clin Psychopharmacol; 2011 Jan; 26(1):11-24. PubMed ID: 20881846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
